Plasma aldosterone is related to severity of obstructive sleep apnea in subjects with resistant hypertension
Obstructive sleep apnea (OSA) and primary aldosteronism are common in subjects with resistant hypertension; it is unknown, however, if the two disorders are causally related. This study relates plasma aldosterone and renin levels to OSA severity in subjects with resistant hypertension, and in those...
Saved in:
Published in | Chest Vol. 131; no. 2; p. 453 |
---|---|
Main Authors | , , , , , |
Format | Journal Article |
Language | English |
Published |
United States
01.02.2007
|
Subjects | |
Online Access | Get more information |
ISSN | 0012-3692 |
DOI | 10.1378/chest.06-1442 |
Cover
Loading…
Abstract | Obstructive sleep apnea (OSA) and primary aldosteronism are common in subjects with resistant hypertension; it is unknown, however, if the two disorders are causally related. This study relates plasma aldosterone and renin levels to OSA severity in subjects with resistant hypertension, and in those with equally severe OSA but without resistant hypertension serving as control subjects.
Seventy-one consecutive subjects referred to the University of Alabama at Birmingham (UAB) for resistant hypertension (BP uncontrolled on three medications) and 29 control subjects referred to UAB Sleep Disorders Center for suspected OSA were prospectively evaluated by an early morning plasma aldosterone concentration (PAC) and renin level, and by overnight, attended polysomnography.
OSA (apnea-hypopnea index [AHI] > or = 5/h) was present in 85% of subjects with resistant hypertension. In these subjects, PAC correlated with AHI (rho = 0.44, p = 0.0002) but not renin concentration. Median PAC was significantly lower in control subjects compared to subjects with resistant hypertension (5.5 ng/dL vs 11.0 ng/dL, p < 0.05) and not related to AHI. In male subjects compared to female subjects with resistant hypertension, OSA was more common (90% vs 77%) and more severe (median AHI, 20.8/h vs 10.8/h; p = 0.01), and median PAC was significantly higher (12.0 ng/dL vs 8.8 ng/dL, p = 0.006).
OSA is extremely common in subjects with resistant hypertension. A significant correlation between PAC and OSA severity is observed in subjects with resistant hypertension but not in control subjects. While cause and effect cannot be inferred, the data suggest that aldosterone excess may contribute to OSA severity. |
---|---|
AbstractList | Obstructive sleep apnea (OSA) and primary aldosteronism are common in subjects with resistant hypertension; it is unknown, however, if the two disorders are causally related. This study relates plasma aldosterone and renin levels to OSA severity in subjects with resistant hypertension, and in those with equally severe OSA but without resistant hypertension serving as control subjects.
Seventy-one consecutive subjects referred to the University of Alabama at Birmingham (UAB) for resistant hypertension (BP uncontrolled on three medications) and 29 control subjects referred to UAB Sleep Disorders Center for suspected OSA were prospectively evaluated by an early morning plasma aldosterone concentration (PAC) and renin level, and by overnight, attended polysomnography.
OSA (apnea-hypopnea index [AHI] > or = 5/h) was present in 85% of subjects with resistant hypertension. In these subjects, PAC correlated with AHI (rho = 0.44, p = 0.0002) but not renin concentration. Median PAC was significantly lower in control subjects compared to subjects with resistant hypertension (5.5 ng/dL vs 11.0 ng/dL, p < 0.05) and not related to AHI. In male subjects compared to female subjects with resistant hypertension, OSA was more common (90% vs 77%) and more severe (median AHI, 20.8/h vs 10.8/h; p = 0.01), and median PAC was significantly higher (12.0 ng/dL vs 8.8 ng/dL, p = 0.006).
OSA is extremely common in subjects with resistant hypertension. A significant correlation between PAC and OSA severity is observed in subjects with resistant hypertension but not in control subjects. While cause and effect cannot be inferred, the data suggest that aldosterone excess may contribute to OSA severity. |
Author | Cofield, Stacey S Harding, Susan M Boedefeld, Robyn L Nishizaka, Mari K Pratt-Ubunama, Monique N Calhoun, David A |
Author_xml | – sequence: 1 givenname: Monique N surname: Pratt-Ubunama fullname: Pratt-Ubunama, Monique N organization: Vascular Biology and Hypertension Program, Division of Cardiovascular Disease, University of Alabama at Birmingham, Birmingham, AL, USA – sequence: 2 givenname: Mari K surname: Nishizaka fullname: Nishizaka, Mari K – sequence: 3 givenname: Robyn L surname: Boedefeld fullname: Boedefeld, Robyn L – sequence: 4 givenname: Stacey S surname: Cofield fullname: Cofield, Stacey S – sequence: 5 givenname: Susan M surname: Harding fullname: Harding, Susan M – sequence: 6 givenname: David A surname: Calhoun fullname: Calhoun, David A |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/17296647$$D View this record in MEDLINE/PubMed |
BookMark | eNo1j8tOwzAQRb0oog9YskX-gRSP4zjNElW8pEqwgHU1diaqq9SJMk5R_55IwOreu7hHOksxi10kIe5ArSEvNw_-QJzWymZgjJ6JhVKgs9xWei6WzEc1bajstZhDqStrTbkQ7UeLfEKJbd1xomECysByoBYT1TJ1kulMQ0gX2TWyc5yG0adwJsktUS-xj4QyRMmjO5JPLL9DOkx_DpwwJnm49DQkihy6eCOuGmyZbv9yJb6enz63r9nu_eVt-7jLvCmKlBUWcgA3da2c0YVTUDhUk5O3CKp2BQJs8o1qGldXrrSGau0aJDIeGvR6Je5_uf3oTlTv-yGccLjs_7X1D8eeXQE |
CitedBy_id | crossref_primary_10_1016_j_hfc_2011_11_001 crossref_primary_10_1016_S1261_694X_08_74610_8 crossref_primary_10_1371_journal_pone_0204390 crossref_primary_10_1155_2017_8295010 crossref_primary_10_1007_s11906_014_0476_2 crossref_primary_10_1007_s00392_010_0148_4 crossref_primary_10_1016_j_rmr_2019_07_011 crossref_primary_10_1177_0300060519868337 crossref_primary_10_1038_ajh_2009_220 crossref_primary_10_1016_j_jash_2009_01_001 crossref_primary_10_1007_s10557_010_6256_6 crossref_primary_10_1016_j_chroma_2008_05_034 crossref_primary_10_1016_j_cjca_2015_05_003 crossref_primary_10_1164_rccm_201505_0998OC crossref_primary_10_26442_SG29588 crossref_primary_10_1210_er_2017_00054 crossref_primary_10_1007_s11695_023_07031_1 crossref_primary_10_3390_endocrines3010003 crossref_primary_10_1007_BF03401320 crossref_primary_10_1210_clinem_dgae415 crossref_primary_10_1378_chest_07_1170 crossref_primary_10_1007_s11906_009_0055_0 crossref_primary_10_1161_HYPERTENSIONAHA_120_16902 crossref_primary_10_1097_CRD_0b013e318223bd08 crossref_primary_10_38109_2075_082X_2022_3_41_47 crossref_primary_10_1177_0300060520954691 crossref_primary_10_1016_j_ejphar_2015_06_024 crossref_primary_10_1038_jhh_2014_94 crossref_primary_10_1097_MNH_0b013e32835623f5 crossref_primary_10_1111_j_1751_7176_2008_07309_x crossref_primary_10_1007_s11892_010_0161_z crossref_primary_10_1016_j_amjmed_2021_07_041 crossref_primary_10_1210_jc_2009_1912 crossref_primary_10_1183_09031936_00226711 crossref_primary_10_1007_s11560_007_0119_6 crossref_primary_10_12688_f1000research_21669_1 crossref_primary_10_1038_hr_2015_19 crossref_primary_10_18786_2072_0505_2019_47_023 crossref_primary_10_1093_ajh_hpac091 crossref_primary_10_1161_HYP_0000000000000084 crossref_primary_10_1080_14779072_2024_2401875 crossref_primary_10_1016_j_jicc_2015_05_016 crossref_primary_10_1038_s41440_024_01970_7 crossref_primary_10_1155_2013_193010 crossref_primary_10_3390_jcm10143099 crossref_primary_10_3238_arztebl_2011_0725 crossref_primary_10_23736_S0026_4806_23_08466_5 crossref_primary_10_1378_chest_09_2954 crossref_primary_10_1007_s11906_010_0112_8 crossref_primary_10_1007_s40292_016_0136_5 crossref_primary_10_1016_j_nephro_2010_11_007 crossref_primary_10_1097_CM9_0000000000003431 crossref_primary_10_1016_j_jacc_2008_08_036 crossref_primary_10_1007_s11906_010_0135_1 crossref_primary_10_1016_j_yjmcc_2025_03_008 crossref_primary_10_4103_nmj_NMJ_129_19 crossref_primary_10_1007_s11936_019_0790_8 crossref_primary_10_1111_jch_12639 crossref_primary_10_1093_ajh_hpac079 crossref_primary_10_1016_j_smrv_2021_101473 crossref_primary_10_1007_s11906_008_0042_x crossref_primary_10_1016_j_ccl_2010_07_002 crossref_primary_10_1055_s_0038_1626082 crossref_primary_10_1146_annurev_med_042711_135929 crossref_primary_10_1371_journal_pone_0089656 crossref_primary_10_3109_10641963_2013_804546 crossref_primary_10_1371_journal_pone_0192671 crossref_primary_10_1183_13993003_01261_2017 crossref_primary_10_1097_MNH_0000000000000047 crossref_primary_10_1016_j_rmr_2013_12_003 crossref_primary_10_1007_s00108_008_2194_9 crossref_primary_10_1016_j_ddmod_2011_02_006 crossref_primary_10_2147_IBPC_S223334 crossref_primary_10_1038_srep45241 crossref_primary_10_1113_jphysiol_2012_245159 crossref_primary_10_1111_jch_14269 crossref_primary_10_1007_s11906_022_01181_w crossref_primary_10_1097_HJH_0b013e3282a9be30 crossref_primary_10_1007_s11906_007_0095_2 crossref_primary_10_1177_1076029610389023 crossref_primary_10_1016_j_ccl_2014_09_003 crossref_primary_10_1016_j_jss_2018_10_040 crossref_primary_10_1016_j_pcad_2008_02_004 crossref_primary_10_1097_HJH_0b013e3283492219 crossref_primary_10_3390_ijms24032245 crossref_primary_10_1055_a_1133_7255 crossref_primary_10_3389_fmed_2023_1200952 crossref_primary_10_1097_HJH_0000000000000238 crossref_primary_10_1161_HYPERTENSIONAHA_116_07806 crossref_primary_10_1111_1471_0528_12885 crossref_primary_10_1007_s00108_008_2195_8 crossref_primary_10_1016_j_ijcard_2016_11_069 crossref_primary_10_1016_j_ccep_2012_06_009 crossref_primary_10_1016_j_cjca_2012_03_010 crossref_primary_10_1038_hr_2009_56 crossref_primary_10_1038_hr_2014_80 crossref_primary_10_1016_j_semnephrol_2014_08_006 crossref_primary_10_1007_s11886_009_0059_z crossref_primary_10_3389_fendo_2022_976979 crossref_primary_10_4061_2011_947246 crossref_primary_10_1097_HJH_0000000000002520 crossref_primary_10_1111_resp_12840 crossref_primary_10_1161_CIRCULATIONAHA_118_036675 crossref_primary_10_1210_clinem_dgaa952 crossref_primary_10_1016_j_cjca_2015_04_022 crossref_primary_10_1053_j_ajkd_2020_04_017 crossref_primary_10_1161_CIRCULATIONAHA_111_029892 crossref_primary_10_3389_fcvm_2021_798364 crossref_primary_10_1007_s10741_011_9286_7 crossref_primary_10_1097_HJH_0000000000000108 crossref_primary_10_1111_j_1365_2869_2010_00839_x crossref_primary_10_2217_fca_10_123 crossref_primary_10_1038_hr_2016_11 crossref_primary_10_1038_jhh_2009_96 crossref_primary_10_1111_jch_12170 crossref_primary_10_12677_ACM_2023_133641 crossref_primary_10_1038_jhh_2011_47 crossref_primary_10_1038_jhh_2017_28 crossref_primary_10_1038_nrcardio_2012_141 crossref_primary_10_1007_s11906_025_01323_w crossref_primary_10_1378_chest_12_0802 crossref_primary_10_1097_HJH_0b013e32833b9c63 crossref_primary_10_1016_S2213_2600_12_70051_6 crossref_primary_10_1038_hr_2009_73 crossref_primary_10_1164_rccm_201502_0383OC crossref_primary_10_4061_2011_598694 crossref_primary_10_4061_2011_236239 crossref_primary_10_1111_jch_13259 crossref_primary_10_1007_s40292_014_0056_1 crossref_primary_10_1111_jsr_13726 crossref_primary_10_1186_s12872_017_0542_1 crossref_primary_10_1210_jc_2008_2116 crossref_primary_10_1016_j_amjmed_2016_01_039 crossref_primary_10_1513_AnnalsATS_201602_126OC crossref_primary_10_1093_ajh_hpad022 crossref_primary_10_1016_S0140_6736_08_61622_0 crossref_primary_10_4061_2011_837817 crossref_primary_10_3389_fmed_2025_1497703 crossref_primary_10_3390_jcm8111872 crossref_primary_10_18705_1607_419X_2012_18_6_514_521 crossref_primary_10_1007_s11906_018_0819_5 crossref_primary_10_1007_s11906_017_0728_z crossref_primary_10_1007_s11906_012_0289_0 crossref_primary_10_1007_s11906_016_0641_x crossref_primary_10_1097_HJH_0000000000003822 crossref_primary_10_7189_jogh_08_010405 crossref_primary_10_1097_HJH_0b013e32833f0e7e crossref_primary_10_1164_rccm_202003_0586UP crossref_primary_10_3109_03009734_2012_707253 crossref_primary_10_1002_alr_23079 crossref_primary_10_1007_s12020_024_03798_0 crossref_primary_10_1016_j_jash_2011_05_003 crossref_primary_10_3390_jcm9030836 crossref_primary_10_1253_circj_CJ_23_0489 crossref_primary_10_4061_2011_162804 crossref_primary_10_1161_HYPERTENSIONAHA_119_13935 crossref_primary_10_1155_2015_408574 crossref_primary_10_4061_2011_340929 crossref_primary_10_1164_rccm_201403_0526OC crossref_primary_10_1016_j_sleep_2014_05_022 crossref_primary_10_1016_j_jacc_2008_05_002 crossref_primary_10_1161_HYPERTENSIONAHA_113_00613 crossref_primary_10_1111_jch_14558 crossref_primary_10_1007_s11906_019_0974_3 crossref_primary_10_1586_14779072_2013_851002 crossref_primary_10_1016_j_jicc_2015_03_020 crossref_primary_10_1155_2013_356280 crossref_primary_10_1161_CIRCULATIONAHA_109_895235 crossref_primary_10_3389_fendo_2022_1016804 crossref_primary_10_1016_j_smrv_2019_07_001 crossref_primary_10_1016_j_jash_2010_03_005 crossref_primary_10_1161_CIRCRESAHA_118_310783 crossref_primary_10_2147_NSS_S340946 crossref_primary_10_3389_fphys_2019_00465 crossref_primary_10_1007_s11325_015_1311_y crossref_primary_10_1007_s11906_014_0459_3 crossref_primary_10_1586_erc_09_120 crossref_primary_10_1038_s41371_019_0294_8 crossref_primary_10_17352_2455_2976_000001 crossref_primary_10_1536_ihj_14_034 crossref_primary_10_1093_eurheartj_ehs046 crossref_primary_10_1007_s11906_008_0045_7 crossref_primary_10_3810_pgm_2012_01_2519 crossref_primary_10_1007_s12020_024_03751_1 crossref_primary_10_1038_jhh_2015_15 crossref_primary_10_1016_j_jsmc_2017_01_003 crossref_primary_10_1038_jhh_2008_147 crossref_primary_10_1007_s11325_012_0755_6 crossref_primary_10_1016_j_pop_2008_06_001 crossref_primary_10_3810_pgm_2012_01_2520 crossref_primary_10_1161_HYPERTENSIONAHA_118_11780 crossref_primary_10_1097_HJH_0000000000000047 crossref_primary_10_18705_1607_419X_2012_18_3_184_190 crossref_primary_10_1097_HJH_0000000000001254 crossref_primary_10_1093_ajh_hpaa042 crossref_primary_10_1161_HYPERTENSIONAHA_116_07316 crossref_primary_10_1007_s40618_015_0338_z crossref_primary_10_1016_j_semnephrol_2007_07_009 crossref_primary_10_1161_CIRCRESAHA_118_312156 crossref_primary_10_1586_ers_09_10 crossref_primary_10_1378_chest_14_0596 crossref_primary_10_1016_j_pcad_2018_07_005 crossref_primary_10_1097_HJH_0b013e328336ed85 crossref_primary_10_1007_s11906_013_0345_4 crossref_primary_10_2174_1573398X18666220915111251 crossref_primary_10_1152_japplphysiol_00689_2009 crossref_primary_10_1161_HYPERTENSIONAHA_120_16378 crossref_primary_10_1007_s11906_013_0411_y crossref_primary_10_1111_j_1751_7176_2008_00012_x crossref_primary_10_1016_j_jacc_2015_06_1315 crossref_primary_10_1002_hep_22143 crossref_primary_10_1097_HJH_0b013e328350e53b crossref_primary_10_1007_s11596_016_1636_1 crossref_primary_10_3109_10641963_2015_1131290 crossref_primary_10_1016_j_ppotor_2014_02_004 crossref_primary_10_1016_j_metabol_2018_03_008 crossref_primary_10_1378_chest_15_0697 crossref_primary_10_1038_s41440_019_0314_7 crossref_primary_10_1371_journal_pone_0084362 crossref_primary_10_1586_14779072_2016_1132626 crossref_primary_10_1016_S1877_1203_13_70407_5 crossref_primary_10_1159_000450796 crossref_primary_10_1161_CIRCULATIONAHA_107_189420 crossref_primary_10_15829_1728_8800_2021_2845 |
ContentType | Journal Article |
DBID | CGR CUY CVF ECM EIF NPM |
DOI | 10.1378/chest.06-1442 |
DatabaseName | Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed |
DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) |
DatabaseTitleList | MEDLINE |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | no_fulltext_linktorsrc |
Discipline | Medicine |
ExternalDocumentID | 17296647 |
Genre | Journal Article |
GroupedDBID | --- .1- .55 .FO .GJ .XZ 08P 0R~ 18M 1P~ 29B 2WC 354 36B 3O- 457 53G 5GY 5RE 5RS 6J9 6PF 7RV 7X7 88E 8AO 8C1 8F7 8FI 8FJ AAEDT AAEDW AAKAS AAKUH AALRI AAWTL AAXUO AAYWO ABDBF ABDQB ABJNI ABLJU ABMAC ABOCM ABUWG ACBMB ACGFO ACGFS ACGUR ACUHS ACVFH ADBBV ADCNI ADGHP ADVLN ADZCM AENEX AEUPX AEVXI AFCTW AFETI AFFNX AFJKZ AFKRA AFPUW AFRHN AFTJW AGCQF AGHFR AHMBA AI. AIGII AITUG AJUYK AKBMS AKRWK AKYEP ALIPV ALMA_UNASSIGNED_HOLDINGS AMRAJ APXCP AZQEC B0M BCGUY BENPR BKEYQ BKNYI BPHCQ BVXVI C1A C45 CCPQU CGR CS3 CUY CVF DU5 EAP EAS EBC EBD EBS ECM EFKBS EHN EIF EJD EMK ENC EPT ESX EX3 F5P FDB FYUFA GD~ H13 HMCUK HX~ HZ~ IH2 INR J5H K9- L7B LXL LXN M0R M1P M5~ MJL MV1 N4W N9A NAPCQ NEJ NPM O6. O9- OB3 OBH ODZKP OFXIZ OGROG OHH OI- OU. OVD OVIDX P2P PCD PHGZM PHGZT PJZUB PPXIY PQQKQ PROAC PSQYO Q~Q RIG ROL SJN SSZ TCP TEORI TR2 TUS TWZ UKHRP VH1 W8F WH7 WOQ WOW X7M XOL YFH YHG YOC YQJ Z5R ZGI ZRQ ZXP ZY1 ~8M |
ID | FETCH-LOGICAL-c455t-561311b45520b425b015ba0442c6a10db5a118380ffbd9b764ed2bfaee4c1fac2 |
ISSN | 0012-3692 |
IngestDate | Mon Jul 21 05:51:12 EDT 2025 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 2 |
Language | English |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-c455t-561311b45520b425b015ba0442c6a10db5a118380ffbd9b764ed2bfaee4c1fac2 |
PMID | 17296647 |
ParticipantIDs | pubmed_primary_17296647 |
PublicationCentury | 2000 |
PublicationDate | 2007-02-01 |
PublicationDateYYYYMMDD | 2007-02-01 |
PublicationDate_xml | – month: 02 year: 2007 text: 2007-02-01 day: 01 |
PublicationDecade | 2000 |
PublicationPlace | United States |
PublicationPlace_xml | – name: United States |
PublicationTitle | Chest |
PublicationTitleAlternate | Chest |
PublicationYear | 2007 |
SSID | ssj0001196 |
Score | 2.3807619 |
Snippet | Obstructive sleep apnea (OSA) and primary aldosteronism are common in subjects with resistant hypertension; it is unknown, however, if the two disorders are... |
SourceID | pubmed |
SourceType | Index Database |
StartPage | 453 |
SubjectTerms | Adult Aged Aldosterone - blood Case-Control Studies Female Humans Hypertension - blood Hypertension - complications Male Middle Aged Polysomnography Prospective Studies Respiratory Function Tests Severity of Illness Index Sleep Apnea, Obstructive - blood Sleep Apnea, Obstructive - complications |
Title | Plasma aldosterone is related to severity of obstructive sleep apnea in subjects with resistant hypertension |
URI | https://www.ncbi.nlm.nih.gov/pubmed/17296647 |
Volume | 131 |
hasFullText | |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1La9tAEF6cBkovoekrSdOyh96EUklePXxsQ0ooJIQSQ25hZx_ErS0ZWy40fyJ_uTOrlSwnbWl7EUILQtJ8Gn0zmvmGsXfEerVWNsyRK4RCZhDK3MShgiKxaTESRlC_89l5djoWn6_Sq8Hgrle1tKrhSN3-sq_kf6yKx9Cu1CX7D5btTooHcB_ti1u0MG7_ysYXSH1nMpBTTa0ai4oUQJZNewrySGSV-NkzC190UYHXiv1uguXUmHkg5yX1SZbBcgVfXVWHy8piAE6ksqyDGwxSF67E3RuvlTS4aX9KkVMlHeRwDKtSzhwTJTdBorDdT55zynPdym_SNwdN1rnVj5XRxvop2V8q-FEGXTb6uOrmZyMlVuTlNnIUeVvWvPa7JI2YjTb97jDuASzpeVHR6Ac_8O7DnDoW3CCxIxofJBphrp6l5zNnamRlGMY1Up5_Xr0ntt0ubbEtDDtojiolf_yHPY7duLfuZrxkK17V-41rIiFaf557wYojLZdP2Y6PNviHBjq7bGDKZ-zxma-neM6mDYJ4D0F8suQeQbyueIsgXlneQxB3COIOQXxS8hZBnBDEOwTxPoJesPGnk8vj09DP3wiVSNM6pNgyjgH3kwjQtwNSR5AR3qHKZBxpSCWGp8Mishb0CPJMGJ2AlcYIFVupkpfsUYkXvsf4EEgUSo8U9WILVRTC5gJMEiVaWJnn--xV85yu543IynX7BA9-u_KaPVlj7ZBtW3yrzRukiDW8dYb7CQPbal4 |
linkProvider | National Library of Medicine |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Plasma+aldosterone+is+related+to+severity+of+obstructive+sleep+apnea+in+subjects+with+resistant+hypertension&rft.jtitle=Chest&rft.au=Pratt-Ubunama%2C+Monique+N&rft.au=Nishizaka%2C+Mari+K&rft.au=Boedefeld%2C+Robyn+L&rft.au=Cofield%2C+Stacey+S&rft.date=2007-02-01&rft.issn=0012-3692&rft.volume=131&rft.issue=2&rft.spage=453&rft_id=info:doi/10.1378%2Fchest.06-1442&rft_id=info%3Apmid%2F17296647&rft_id=info%3Apmid%2F17296647&rft.externalDocID=17296647 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0012-3692&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0012-3692&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0012-3692&client=summon |